Cargando…
Neural deficits in a mouse model of PACS1 syndrome are corrected with PACS1- or HDAC6-targeting therapy
PACS1 syndrome is a neurodevelopmental disorder (NDD) caused by a recurrent de novo missense mutation in PACS1 (p.Arg203Trp (PACS1(R203W))). The mechanism by which PACS1(R203W) causes PACS1 syndrome is unknown, and no curative treatment is available. Here, we use patient cells and PACS1 syndrome mic...
Autores principales: | Villar-Pazos, Sabrina, Thomas, Laurel, Yang, Yunhan, Chen, Kun, Lyles, Jenea B., Deitch, Bradley J., Ochaba, Joseph, Ling, Karen, Powers, Berit, Gingras, Sebastien, Kordasiewicz, Holly B., Grubisha, Melanie J., Huang, Yanhua H., Thomas, Gary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582149/ https://www.ncbi.nlm.nih.gov/pubmed/37848409 http://dx.doi.org/10.1038/s41467-023-42176-8 |
Ejemplares similares
-
RNA-targeted therapy corrects neuronal deficits in PACS1 syndrome mice
por: Villar-Pazos, Sabrina, et al.
Publicado: (2023) -
PAC in FACTT: Time to PAC it in?
por: Mansour, Wissam, et al.
Publicado: (2008) -
An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I
por: Dikeakos, Jimmy D., et al.
Publicado: (2012) -
The Multifunctional Protein PACS-1 is Required for HDAC2 and HDAC3 Dependent Chromatin Maturation and Genomic Stability
por: Mani, Chinnadurai, et al.
Publicado: (2020) -
Budgeting for PACS
por: Sim, LH
Publicado: (2008)